Burden of Clostridium difficile on the healthcare system

Erik R Dubberke, Margaret A Olsen, Erik R Dubberke, Margaret A Olsen

Abstract

There are few high-quality studies of the costs of Clostridium difficile infection (CDI), and the majority of studies focus on the costs of CDI in acute-care facilities. Analysis of the best available data, from 2008, indicates that CDI may have resulted in $4.8 billion in excess costs in US acute-care facilities. Other areas of CDI-attributable excess costs that need to be investigated are costs of increased discharges to long-term care facilities, of CDI with onset in long-term care facilities, of recurrent CDI, and of additional adverse events caused by CDI.

References

    1. Dubberke ER, Wertheimer AI. Review of current literature on the economic burden of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009;30:57–66.
    1. Ghantoji SS, Sail K, Lairson DR, Dupont HL, Garey KW. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect. 2010;74:309–18.
    1. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis. 2008;46:497–504.
    1. Stuart EA. Matching methods for causal inference: a review and a look forward. Stat Sci. 2010;25:1–21.
    1. Dubberke ER, Butler AM, Reske KA, et al. Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients. Emerg Infect Dis. 2008;14:1031–8.
    1. Campbell RJ, Giljahn L, Machesky K, et al. Clostridium difficile infection in Ohio hospitals and nursing homes during 2006. Infect Control Hosp Epidemiol. 2009;30:526–33.
    1. McFarland LV, Surawicz CM, Rubin MS, Fekety R, Elmer GW, Greenberg RN. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect Control Hosp Epidemiol. 1999;20:43–9.
    1. O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007;28:1219–27.
    1. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34:346–53.
    1. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000;342:390–7.
    1. Song X, Bartlett JG, Speck K, Naegeli A, Carroll K, Perl TM. Rising economic impact of Clostridium difficile-associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol. 2008;29:823–8.
    1. Perencevich EN, Thom KA. Commentary: preventing Clostridium difficile-associated disease: is it time to pay the piper? Infect Control Hosp Epidemiol. 2008;29:829–31.
    1. Agency for Healthcare and Quality Research. Welcome to HCUPnet. Available at: . Accessed 12 September 2011.
    1. Dubberke ER, Gerding DN, Classen D, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29(1):S81–92.
    1. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ. Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2007;45:1543–9.
    1. Decker FH. Outcomes and length of Medicare nursing home stays: the role of registered nurses and physical therapists. Am J Med Qual. 2008;23:465–74.
    1. Jones A. The National Nursing Home Survey: 1999 summary. Vital Health Stat. 2002;13:1–116.
    1. Jones AL, Dwyer LL, Bercovitz AR, Strahan GW. The National Nursing Home Survey: 2004 overview. Vital Health Stat. 2009;13:1–155.
    1. Owens PL, Russo CA, Spector W, Mutter R. Emergency department visits for injurious falls among the elderly, 2006: Statistical Brief #80. Healthcare Cost and Utilization Project. Agency for Healthcare Research and Quality. Available at: . Accessed 10 September 2011.
    1. Samaras N, Chevalley T, Samaras D, Gold G. Older patients in the emergency department: a review. Ann Emerg Med. 2010;56:261–9.
    1. Caffrey C. Potentially preventable emergency department visits by nursing home residents: United States, 2004. NCHS Data Brief. 2010:1–8.
    1. Tzeng HM. Understanding the prevalence of inpatient falls associated with toileting in adult acute care settings. J Nurs Care Qual. 2010;25:22–30.
    1. Sherrington C, Lord SR, Close JC, et al. Development of a tool for prediction of falls in rehabilitation settings (Predict_FIRST): a prospective cohort study. J Rehabil Med. 2010;42:482–8.
    1. Krauss MJ, Evanoff B, Hitcho E, et al. A case-control study of patient, medication, and care-related risk factors for inpatient falls. J Gen Intern Med. 2005;20:116–22.
    1. Louie TJ, Miller MA, Mullane KM, et al. OPT-80-003 Clinical Study Group. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364:422–31.
    1. Lowy I, Molrine DC, Leav BA, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med. 2010;362:197–205.
    1. Dubberke ER, Ackerman SJ, Chen YJ, Baik R, Hugentobler E. Rates of recurrence and mortality among patients with a diagnosis of Clostridium difficile infection in the United States [abstract 152]. Paper presented at: 21st Annual Meeting of the Society for Healthcare Epidemiology of America; 1–4 April 2011; Dallas, Texas.
    1. Dubberke ER, Butler AM, Yokoe DS, et al. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol. 2010;31:1030–7.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa